Liu Qing, Dai Zhibing, Wu Junshen, Ji Suzhi, Bai Jingping, Jiang Renbing
Department of Bone and Soft Tissue, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
J Invest Surg. 2020 Feb;33(2):191-197. doi: 10.1080/08941939.2018.1483445. Epub 2018 Oct 31.
The purpose of this study was to explore the feasibility and clinical applicability of a modified type V resection method for malignant bone tumors of the proximal humerus. The relevant anatomic MRI data from 30 normal adult shoulder joints were measured to analyze the feasibility of the modified type V resection method for malignant bone tumors of the proximal humerus. Sixteen patients with malignant bone tumors of the proximal humerus were treated with modified radical resection between March 2012 and April 2017. Recurrence of tumor was evaluated after surgery, and shoulder function was assessed according to the Enneking skeletal muscle tumor function scoring system. Radiographic results showed that the modified type V resection method was feasible, and within the allowable range of the maximum longitudinal diameter (<29.8 mm) and depth (<4 mm). Surgery was successfully completed in all 16 cases, and pathological examination suggested that the purposes for radical resection had been achieved. All patients were followed up over 3-49 months (mean, 15.6 months). One patient had local recurrence at 12 months after surgery, and we performed upper limb amputation. The remaining 15 patients had good prosthesis survival. At the final follow-up, shoulder joint function had recovered compared with preoperative levels, with a mean Enneking score of 25.8 points (range, 24-27 points). Modified type V resection may be feasible for treating tumors of the proximal humerus, maintaining good early shoulder function.
本研究的目的是探讨改良Ⅴ型切除术治疗肱骨近端恶性骨肿瘤的可行性及临床适用性。测量30例正常成人肩关节的相关解剖学MRI数据,以分析改良Ⅴ型切除术治疗肱骨近端恶性骨肿瘤的可行性。2012年3月至2017年4月期间,对16例肱骨近端恶性骨肿瘤患者行改良根治性切除术。术后评估肿瘤复发情况,并根据Enneking骨骼肌肿瘤功能评分系统评估肩关节功能。影像学结果显示,改良Ⅴ型切除术可行,最大纵径(<29.8 mm)和深度(<4 mm)在允许范围内。16例手术均顺利完成,病理检查提示根治性切除目的已达到。所有患者均获随访3~49个月(平均15.6个月)。1例患者术后12个月局部复发,行上肢截肢术。其余15例患者假体存活良好。末次随访时,肩关节功能较术前有所恢复,Enneking评分平均为25.8分(范围24~27分)。改良Ⅴ型切除术治疗肱骨近端肿瘤可能可行,并能保持早期良好的肩关节功能。